MARÍA ARANZAZU
MARTÍNEZ CABALLERO
Catedrática de universidad
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublications en collaboration avec des chercheurs de Hospital Universitari de Bellvitge (1)
2015
-
Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A randomised, open-label, non-inferiority trial
The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 785-792